- Investor's Business Daily•3 days ago
Galenica, whose joint venture with Fresenius has rights to Relypsa's drug Veltassa, is taking full ownership.
Fresenius Medical Care AG & Co. KGAANYSE
After hours: 44.370.03 (0.07%) as of 5:16 PM EDT
|Bid||44.32 x 400|
|Ask||44.33 x 100|
|52wk Range||36.89 - 45.85|
|Day's Range||44.25 - 44.52|
|Avg Vol (3m)||163,117|
As of 4:02 PM EDT. Market closed.